TECX Q2 2020 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$634M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$301,000

Operating Income

-$29M

Net Income

-$29M

EPS (Diluted)

$-9.58

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$256M

Total Liabilities

$16M

Stockholders' Equity

$240M

Cash & Equivalents

$244M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$301,000	-$200,000	-50.5%
Operating Income	-$29M	-$17M	-73.7%
Net Income	-$29M	-$16M	-79.6%